News
News
- ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
03/18/2020 / 10:18 - GlobeNewswire - Vectura Group plc: 2019 Preliminary Results
03/17/2020 / 13:00 - GlobeNewswire - Paratek Pharmaceuticals Announces the Submission of the pre-Emergency Use Authorization Application to the FDA for NUZYRA• (omadacycline)
03/10/2020 / 21:01 - GlobeNewswire - Athenex Announces FDA Acceptance for Filing of U.S. NDA for Tirbanibulin Ointment in Actinic Keratosis
03/09/2020 / 12:00 - GlobeNewswire - Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
03/02/2020 / 22:05 - GlobeNewswire - Athenex’s Partner Almirall Announces EMA Acceptance for Filing of Marketing Authorization Application (MAA) for Tirbanibulin Ointment in Actinic Keratosis
03/02/2020 / 16:19 - GlobeNewswire - Athenex, Inc. Reports Fourth Quarter and Year Ended December 31, 2019 Financial Results and Provides Corporate Update
02/27/2020 / 13:00 - GlobeNewswire - Paratek Pharmaceuticals to Present at the SVB Leerink 9th Annual Global Healthcare Conference
02/26/2020 / 14:00 - GlobeNewswire - Paratek Pharmaceuticals Announces Full Year 2019 Total Revenues of $16.5 Million including NUZYRA® (omadacycline) Net Sales of $11.5 Million
02/25/2020 / 22:01 - GlobeNewswire - Paratek Announces License Grant to Almirall for SEYSARA® (sarecycline) for Greater China Region
02/24/2020 / 13:00 - GlobeNewswire
Real-time